4591 — Ribomic Income Statement
0.000.00%
- ¥4bn
- ¥772m
Annual income statement for Ribomic, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 121 | 92 | 80.9 | 66 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,036 | 1,333 | 1,877 | 1,854 | 1,156 |
Operating Profit | -915 | -1,241 | -1,796 | -1,789 | -1,156 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -854 | -1,186 | -1,684 | -1,652 | -1,023 |
Provision for Income Taxes | |||||
Net Income After Taxes | -855 | -1,187 | -1,685 | -1,653 | -1,024 |
Net Income Before Extraordinary Items | |||||
Net Income | -855 | -1,187 | -1,685 | -1,653 | -1,024 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -855 | -1,187 | -1,685 | -1,653 | -1,024 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -53.6 | -46.1 | -58.8 | -53.1 | -28 |
Dividends per Share |